The University of Chicago Header Logo

Connection

Richard A. Larson to Receptors, Thrombopoietin

This is a "connection" page, showing publications Richard A. Larson has written about Receptors, Thrombopoietin.
Connection Strength

0.037
  1. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy. Br J Haematol. 2017 09; 178(6):906-913.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.